Dr. Nivashini Murugan

Nivashini Murugan is a South African clinical researcher whose work centers on breast cancer epidemiology and outcomes in high HIV-prevalence settings. Affiliated with leading public academic hospitals in Johannesburg, her research is closely linked to the South African Breast Cancer and HIV Outcomes cohort, advancing understanding of cancer care within resource-constrained health systems.

Her publications explore the intersection of HIV and breast cancer biology, treatment adherence, and survival. Notable contributions include analyses of the association between HIV and triple-negative breast cancer, the impact of HIV on tamoxifen adherence, and receptor-defined survival patterns. This body of work highlights tumor subtype disparities, multimorbidity, and the clinical implications of chronic HIV infection in oncology.

Earlier studies examined surgical management, neoadjuvant chemotherapy use, stage at diagnosis, and trauma surgery, reflecting broad clinical expertise. Collectively, her research emphasizes health system challenges, equity in access to care, and evidence-based strategies to improve outcomes for women with breast cancer in Southern Africa.